Literature DB >> 28374143

DNA damage response and hematological malignancy.

Masatoshi Takagi1.   

Abstract

DNA damage is a serious threat to cellular homeostasis. Damaged DNA leads to genomic instability, mutation, senescence, and/or cell death. DNA damage triggers a cellular response called the DNA damage response (DDR), followed by activation of the DNA repair machinery. DDR both maintains cellular homeostasis and prevents cancer development. Germ line mutation of DDR-associated genes can lead to cancer-susceptible syndromes. Somatic mutation of DDR-associated genes has also been reported in various tumors, including hematological malignancies. Therapeutic approaches that target the DDR and DNA repair are thus now being developed. Understanding the mechanism(s) underlying DDR and DNA repair will increase our knowledge of cancer etiology and facilitate development of cancer therapies.

Entities:  

Keywords:  ATM; Caner susceptible syndrome; DNA damage response; DNA repair; Hematological malignancy

Mesh:

Substances:

Year:  2017        PMID: 28374143     DOI: 10.1007/s12185-017-2226-0

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  65 in total

Review 1.  Initiating cellular stress responses.

Authors:  Christopher J Bakkenist; Michael B Kastan
Journal:  Cell       Date:  2004-07-09       Impact factor: 41.582

2.  A genetic screen identifies BRCA2 and PALB2 as key regulators of G2 checkpoint maintenance.

Authors:  Tobias Menzel; Viola Nähse-Kumpf; Arne Nedergaard Kousholt; Ditte Kjærsgaard Klein; Christin Lund-Andersen; Michael Lees; Jens Vilstrup Johansen; Randi G Syljuåsen; Claus Storgaard Sørensen
Journal:  EMBO Rep       Date:  2011-07-01       Impact factor: 8.807

3.  Assessing 'radiosensitivity' with kinetic profiles of γ-H2AX, 53BP1 and BRCA1 foci.

Authors:  Nathan T Martin; Shareef A Nahas; Rashmi Tunuguntla; Francesca Fike; Richard A Gatti
Journal:  Radiother Oncol       Date:  2011-06-30       Impact factor: 6.280

4.  DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.

Authors:  Jirina Bartkova; Zuzana Horejsí; Karen Koed; Alwin Krämer; Frederic Tort; Karsten Zieger; Per Guldberg; Maxwell Sehested; Jahn M Nesland; Claudia Lukas; Torben Ørntoft; Jiri Lukas; Jiri Bartek
Journal:  Nature       Date:  2005-04-14       Impact factor: 49.962

5.  Inactivation of ataxia telangiectasia mutated gene in B-cell chronic lymphocytic leukaemia.

Authors:  T Stankovic; P Weber; G Stewart; T Bedenham; J Murray; P J Byrd; P A Moss; A M Taylor
Journal:  Lancet       Date:  1999-01-02       Impact factor: 79.321

6.  BRCA1, PARP1 and γH2AX in acute myeloid leukemia: Role as biomarkers of response to the PARP inhibitor olaparib.

Authors:  Isabella Faraoni; Mirco Compagnone; Serena Lavorgna; Daniela Francesca Angelini; Maria Teresa Cencioni; Eleonora Piras; Paola Panetta; Tiziana Ottone; Susanna Dolci; Adriano Venditti; Grazia Graziani; Francesco Lo-Coco
Journal:  Biochim Biophys Acta       Date:  2014-12-05

Review 7.  The clinical manifestation of a defective response to DNA double-strand breaks as exemplified by Nijmegen breakage syndrome.

Authors:  I Demuth; M Digweed
Journal:  Oncogene       Date:  2007-12-10       Impact factor: 9.867

8.  The p53-dependent G1 cell cycle checkpoint pathway and ataxia-telangiectasia.

Authors:  C E Canman; A C Wolff; C Y Chen; A J Fornace; M B Kastan
Journal:  Cancer Res       Date:  1994-10-01       Impact factor: 12.701

9.  ATM-dependent DNA damage-response pathway as a determinant in chronic myelogenous leukemia.

Authors:  Masatoshi Takagi; Masaki Sato; Jinhua Piao; Satoshi Miyamoto; Takeshi Isoda; Masanobu Kitagawa; Hiroaki Honda; Shuki Mizutani
Journal:  DNA Repair (Amst)       Date:  2013-05-19

Review 10.  DNA repair pathways as targets for cancer therapy.

Authors:  Thomas Helleday; Eva Petermann; Cecilia Lundin; Ben Hodgson; Ricky A Sharma
Journal:  Nat Rev Cancer       Date:  2008-03       Impact factor: 60.716

View more
  4 in total

Review 1.  Sensing Bacterial-Induced DNA Damaging Effects via Natural Killer Group 2 Member D Immune Receptor: From Dysbiosis to Autoimmunity and Carcinogenesis.

Authors:  J Luis Espinoza; Mika Minami
Journal:  Front Immunol       Date:  2018-01-25       Impact factor: 7.561

2.  Genetic variations in ATM and H2AX loci contribute to risk of hematological abnormalities in individuals exposed to BTEX chemicals.

Authors:  Samaneh Jafari Roshan; Yaser Mansoori; Seyed Reza Hosseini; Davood Sabour; Abdolreza Daraei
Journal:  J Clin Lab Anal       Date:  2022-03-02       Impact factor: 2.352

3.  Venetoclax enhances DNA damage induced by XPO1 inhibitors: A novel mechanism underlying the synergistic antileukaemic effect in acute myeloid leukaemia.

Authors:  Hanxi Yu; Shuangshuang Wu; Shuang Liu; Xinyu Li; Yuqing Gai; Hai Lin; Yue Wang; Holly Edwards; Yubin Ge; Guan Wang
Journal:  J Cell Mol Med       Date:  2022-03-31       Impact factor: 5.295

Review 4.  PARP1 as a therapeutic target in acute myeloid leukemia and myelodysplastic syndrome.

Authors:  Christina-Nefeli Kontandreopoulou; Panagiotis T Diamantopoulos; Despina Tiblalexi; Nefeli Giannakopoulou; Nora-Athina Viniou
Journal:  Blood Adv       Date:  2021-11-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.